natural killer cells

Nkarta's blood cancer CAR stalls again, with falling response rate forcing it out of the race
Fierce Biotech
Fri, 03/22/24 - 10:47 am
Nkarta
natural killer cells
car
NKX101
Athenex files for bankruptcy, seeks buyer for natural killer cell therapy unit
Fierce Biotech
Mon, 05/15/23 - 06:32 pm
Athenex
bankruptcy
natural killer cells
Gamida lays off 17%, ditches NK cell therapy work to keep blood cancer drug on track
Fierce Biotech
Mon, 03/27/23 - 09:55 am
Gamida Cell
layoffs
omidubicel
natural killer cells
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Fierce Biotech
Mon, 12/19/22 - 11:19 am
Sanofi
Innate Pharma
natural killer cells
solid tumors
Gilead dives deeper into NK cell therapies with Dragonfly deal
Pharmaforum
Tue, 05/3/22 - 10:37 am
Gilead Sciences
natural killer cells
Dragonfly Therapeutics
TriNKET
cancer
Nkarta: at least as good as Fate, at a tenth of the price
EP Vantage
Mon, 04/25/22 - 10:13 am
Nkarta
Fate Therapeutics
natural killer cells
AACR 2022 – Affimed shows that 2021 was no fluke
EP Vantage
Mon, 04/11/22 - 10:26 am
AACR
Affimed
AFM13
natural killer cells
Cancer biotech Indapta nabs $50M for new approach to natural killer cell therapy
MedCity News
Fri, 02/11/22 - 10:29 am
Indapta
natural killer cells
ASH: Senti Bio's gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models
Fierce Biotech
Thu, 12/9/21 - 11:00 am
Senti Biosciences
natural killer cells
AML
CAR-NK
Fate delivers, up to a point
EP Vantage
Fri, 08/20/21 - 12:36 pm
Fate Therapeutics
natural killer cells
CAR-NK
FT596
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site
Fierce Pharma
Wed, 07/14/21 - 10:48 am
Nkarta Therapeutics
natural killer cells
San Francisco
In a move to boost its natural killer candidates, Senti Bio will build out its own San Francisco manufacturing facility
Endpoints
Thu, 06/17/21 - 10:51 am
Senti Biosciences
natural killer cells
drug manufacturing
BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform
Endpoints
Wed, 06/9/21 - 11:09 am
BeiGene
China
natural killer cells
cell therapy
Shoreline Biosciences
Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell Trials
BioSpace
Wed, 04/14/21 - 09:35 am
Celularity
FDA
orphan drugs
natural killer cells
malignant glioma
Nantkwest tries to catch the NK cell wave
EP Vantage
Thu, 01/14/21 - 10:43 am
NantKwest
natural killer cells
pancreatic cancer
Catamaran Bio sails into the CAR-NK waters with a $42M launch round
Endpoints
Mon, 11/23/20 - 10:17 am
Catamaran Bio
CAR-NK
funding
natural killer cells
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Bizjournals
Thu, 09/5/19 - 10:10 am
Nkarta Therapeutics
IPOs
cancer
natural killer cells
CAR-T